In a significant expansion of its life sciences portfolio, global science and technology leader Merck has announced a definitive agreement to purchase Mirus Bio for a staggering $600 million. Mirus Bio, a pioneering life sciences company, specializes in developing transfection reagents, a
Within the dynamic landscape of the Contract Development and Manufacturing Organization (CDMO) industry, strategic alliances are becoming increasingly crucial. The latest collaboration between Japan's AGC Biologics and the Netherlands-based BioConnection illustrates this point poignantly. They have
The biotechnology sector could be on the brink of a substantial change as legislative gears turn with the possibility of the BIOSECURE Act being widened to encompass drug developers. This pivot towards inclusive scrutiny, primarily targeting relationships with Chinese biopharma entities, sparks a
The biopharmaceutical industry is on the cusp of a manufacturing evolution, largely due to advancements in analytical technologies. A key player that has emerged in this transformative period is Raman spectroscopy. Renowned for its rapid, nondestructive analysis capabilities, Raman spectroscopy is
In an era characterized by breakthrough innovations in medical technology, peptide-based nanofiber hydrogels stand out as a transformative advancement in regenerative medicine. Seminal work by researchers at Rice University and the University of Houston exemplifies the innovative thinking that
The dawn of a food revolution is upon us, with synthetic biology at the helm, ready to address critical issues like resource scarcity and population growth. The anticipated SynBioBeta 2024's food and ag panel sessions are likely to showcase significant advances in synthetic biology, signaling a
